HCPCS Code B4172: Parenteral nutrition solution 5.5–7% amino acid

Key Takeaways

HCPCS Code B4172 covers home-mix parenteral nutrition solution with amino acid concentration from 5.5% through 7%, billed in 500 ml units (1 unit = 500 ml).

B4172 is a Level II HCPCS B-code billed through DME MACs, not standard Part A or Part B MACs.

The KX modifier is typically required on B4172 claims to attest that Medicare coverage criteria are met; missing it is the leading denial cause.

Practice management software like Pabau runs pre-submission validation on claims, flagging missing details before they reach the payer to help reduce denials.

Parenteral nutrition billing gets denied more than almost any other DME claim category. The concentration thresholds in the B-code series are narrow, the modifier requirements are strict, and the documentation checklist is long.

One wrong code selection between B4172 and an adjacent B-code can trigger an immediate denial with no path to appeal without corrected records.

HCPCS Code B4172: Definition and code details

HCPCS Code B4172 is the Level II HCPCS code for a home-mix parenteral nutrition (PN) solution containing amino acids at a concentration of 5.5% through 7%, billed in units of 500 ml (1 unit = 500 ml).

It falls within the Enteral and Parenteral Therapy category of the HCPCS B-code series, which covers supplies and nutrients for patients who cannot absorb nutrition through the gastrointestinal tract.

The long descriptor is: Parenteral nutrition solution; amino acid, 5.5% through 7%, (500 ml = 1 unit) – home mix. The short descriptor is: Parenteral sol amino acid 5.

According to the Centers for Medicare and Medicaid Services (CMS) HCPCS overview, HCPCS Level II codes like B4172 are maintained annually and updated each January. Billers should verify the code remains active in the current year’s official CMS HCPCS release before submitting claims.

2026 Medicare reimbursement rate for HCPCS Code B4172

B4172 is reimbursed under the DMEPOS (Durable Medical Equipment, Prosthetics, Orthotics, and Supplies) fee schedule, not the Physician Fee Schedule. The allowed amount for B4172 reflects the prosthetic pricing indicator assigned to the B-code series.

The specific Medicare allowed amount varies by jurisdiction and is updated in the annual CMS DMEPOS fee schedule release. Always verify the current allowed amount directly from the CMS fee schedule tool or your DME MAC’s published fee schedule before billing, as third-party figures may lag behind official updates.

Key reimbursement facts for B4172:

• Claims are submitted to the DME MAC covering the patient’s home address, not the supplier’s location.
• Reimbursement is typically 80% of the Medicare allowed amount after the patient’s Part B deductible; the remaining 20% is the patient’s responsibility or covered by secondary insurance.
• State-level geographic adjusters may affect the final allowed amount. Rates in rural areas may differ from urban jurisdictions.
• Medicare Part B covers home parenteral nutrition under the prosthetic device benefit, not Part D. Billing under the wrong benefit is a common denial cause.

For jurisdiction-specific allowed amounts, contact your DME MAC directly: Noridian Healthcare Solutions administers Jurisdictions A and D, and CGS Administrators administers Jurisdictions B and C.

Related B-codes: Parenteral nutrition HCPCS codes and amino acid series

The home-mix amino acid series for parenteral nutrition covers four HCPCS codes, B4168 through B4178, each tied to a specific concentration range, with 500 ml equal to 1 billing unit.

Selecting the wrong code is the most common claim denial in this category. The concentration used for code selection is the amino acid concentration of the compounded home-mix solution.

Related home-mix codes outside the amino acid series cover the other components of a compounded PN solution: carbohydrates/dextrose (B4164 for 50% or less, B4180 for greater than 50%) and lipids (B4185 and B4187, billed per 10 grams of lipid rather than by unit of volume).

These are separately billable alongside the amino acid code when a home-mix formula is used, as are administration supplies such as HCPCS code A4208.

B4172 applies to solutions compounded with an amino acid concentration anywhere from 5.5% through 7%, so a 6% solution is billed correctly under B4172.

A solution compounded above 7%, up to 8.5%, must be billed under B4176, not B4172; billing B4172 for that higher-concentration solution is a coding error. The AAPC Codify HCPCS lookup provides cross-referenced descriptions for each code in this series to support correct selection.

The billing structure for standalone infusion administration follows a similar logic, covered under CPT code 96365.

ICD-10 diagnosis codes commonly paired with B4172

Every B4172 claim requires a supporting ICD-10-CM diagnosis code that establishes medical necessity. The accepted diagnoses are those recognized under the DME MAC’s Parenteral Nutrition – Correct Coding and Billing policy article for home parenteral nutrition.

Payers vary, but the following codes are most commonly accepted on B4172 claims.

The ICD-10 codes listed above reflect commonly accepted pairings, but your DME MAC’s current policy article governs which diagnoses are covered in your jurisdiction. Always verify against the current policy article before billing.

Accepted diagnosis codes vary by payer and are subject to policy updates. Practices delivering ongoing nutritional support, including those running on metabolic health EMR software, should track these updates each policy cycle.

See also resources on IV therapy clinic setup for broader clinical context on parenteral nutrition service delivery.

Medicare coverage criteria and medical necessity for B4172

Medicare covers home parenteral nutrition under the prosthetic device benefit (Part B), not the drug benefit (Part D). The National Coverage Determination that historically governed this benefit, NCD 180.2 (Enteral and Parenteral Nutritional Therapy), was retired effective January 1, 2022.

CMS determined that no national coverage determination was appropriate, so coverage decisions are now made by the DME MACs directly.

For B4172 to be covered, the patient must meet the medical necessity criteria set out in the DME MAC’s Parenteral Nutrition – Correct Coding and Billing policy article, which still applies the reasonable-and-necessary framework from the retired NCD.

The core eligibility criteria are:

• The patient has a permanently impaired digestive tract that cannot absorb sufficient nutrients through oral or enteral feeding.
• A physician has certified that parenteral nutrition is medically necessary and has documented the underlying condition.
• The condition causing the inability to absorb nutrition is expected to last at least 90 days.
• The patient is being treated in a home setting (home parenteral nutrition) or meets inpatient coverage criteria. Patients on home PN often need other home DME on file too, such as HCPCS code E0265.
• The diagnosis, expected duration, and clinical basis for parenteral nutrition are documented in the physician’s order and the medical record. The Certificate of Medical Necessity (CMN) and DME Information Form (DIF) were discontinued for parenteral and enteral nutrition claims effective January 1, 2023 (CMS MLN Matters SE22002); suppliers no longer complete or submit a CMN, but the same information must still be captured in the order and chart.

For guidance on establishing a compliant infusion service and meeting these criteria operationally, see IV therapy documentation practices. Suppliers should also confirm their enrollment status with the National Supplier Clearinghouse (NSC), as unenrolled suppliers cannot bill DME MACs for parenteral nutrition codes.

Patients with short bowel syndrome following resection may also require separately billed ostomy supplies, such as HCPCS code A4425.

Documentation requirements for HCPCS Code B4172 claims

Missing or incomplete documentation is the second most common cause of B4172 claim denials, after wrong code selection. The DME MAC will request records on post-payment review, and insufficient documentation results in recoupment even if the service was clinically appropriate.

Required documentation for every B4172 claim includes:

• Physician order: a signed, written order from the treating physician specifying the type of PN solution, concentration, volume, frequency, and duration.
• Medical necessity documentation: the diagnosis, expected duration, and clinical basis for parenteral nutrition, captured in the physician’s order and medical record. The CMN and DIF (CMS-10126) were discontinued for parenteral and enteral nutrition claims effective January 1, 2023; suppliers no longer submit these forms, but the underlying information must still be documented.
• Laboratory values: recent labs confirming nutritional status (albumin, pre-albumin, BMP/CMP, weight trend) that support medical necessity.
• Diagnosis documentation: medical records demonstrating the GI condition or malabsorption diagnosis that prevents enteral nutrition.
• Infusion plan: compounding pharmacy records or infusion plan detailing the B4172 solution composition and administration schedule.
• Proof of delivery: supplier delivery records showing the solution was provided to the patient at the correct volume and concentration.

Using IV therapy intake forms at the point of clinical assessment helps capture the required data before billing, rather than assembling records retrospectively when a DME MAC requests them. Digital clinical documentation forms can standardise this process across your team and reduce audit exposure.

Applicable modifiers for HCPCS Code B4172

Modifiers for B4172 are not optional. DME MAC policy articles specify which modifiers are required, and a claim submitted without the correct modifier will deny or be flagged for review. Verify applicable modifiers against your jurisdiction’s current policy article before submitting.

The KX modifier is required when the supplier has documentation on file confirming the patient meets the DME MAC policy article’s coverage criteria. Submitting B4172 without the KX modifier when criteria are met is a billing error, not just a technicality.

It results in an automatic denial that requires a corrected claim to resolve. The CMS Parenteral Nutrition article sets out the current modifier and coverage requirements DME MACs apply to B-code claims.

Common billing errors with B4172 and how to avoid them

The B-code parenteral nutrition series has a higher-than-average denial rate in DMEPOS billing, partly because the concentration thresholds between codes are narrow and the documentation requirements are rigorous. These are the errors that generate the most denials on B4172 claims.

• Wrong concentration code: billing B4176 for a solution compounded at 7.5% amino acid concentration would be correct, since B4176 covers 7% through 8.5%; billing that same solution under B4172 (which covers only 5.5% through 7%) is a coding error that will result in denial if the pharmacy records show the actual concentration. Always cross-check the compounded amino acid concentration against the code descriptor’s range before submitting.
• Missing KX modifier: submitting B4172 without the KX modifier when coverage criteria are met is the single most common denial cause in this code category. The KX modifier must appear on every claim where the supplier has documentation confirming the DME MAC’s policy article criteria are satisfied.
• Incorrect billing units: B4172 is billed in units of 500 ml, with 1 unit equal to 500 ml. Billing the total volume in ml rather than converting to units will result in an overpayment demand on post-payment review.
• Insufficient documentation on file: the physician order and medical record (documenting diagnosis, expected duration, and clinical basis) along with lab values must be in the supplier’s records before the claim is submitted, not assembled afterward. DME MACs conduct post-payment audits, and retroactively collected documentation is often rejected.
• Wrong payer type: billing home parenteral nutrition to a Part D plan rather than Part B Medicare is a fundamental coverage error. PN is covered as a prosthetic device under Part B, not as a drug under Part D.
• Billing before delivery confirmation: claims for B4172 must reflect the date the solution was delivered to the patient, not the date it was ordered or compounded. Delivery records must support the service date on the claim.

Practice management software with built-in claims validation flags missing details and inconsistencies before a claim goes out, catching the error before a denial is issued rather than after.

Reduce B4172 claim denials before they happen

Pabau's claims management tools validate claims before submission, flagging missing details so problems get caught before they turn into denials. See how infusion and DME providers use Pabau to keep denial rates low.

Book a demo

How practice management software simplifies home infusion parenteral nutrition billing

Home infusion parenteral nutrition billing involves more pre-submission steps than most DMEPOS claim types. Before a claim goes out, the supplier must:

• Confirm the final compounded concentration
• Verify the correct B-code
• Attach the KX modifier
• Link the right ICD-10 diagnosis
• Confirm documentation is on file

Manual processes across these steps create multiple points of failure.

Practice management and billing software built for infusion providers addresses each step in the workflow:

• Pre-submission validation: claims are checked for missing or inconsistent details, such as authorization information, before they are submitted, so problems surface while there is still time to fix them.
• Claim scrubbing: general pre-submission checks catch incomplete or inconsistent entries before the claim reaches the payer, cutting down on the back-and-forth of resubmitting corrected claims.
• Documentation workflow: structured documentation templates capture CMN-equivalent data, lab values, and physician orders within the clinical encounter, so the required records are already in the system when billing runs.
• Audit trail: structured client records with time-stamped entries provide a clear audit trail if the DME MAC requests documentation on post-payment review.

For practices that also provide mobile or practice-based infusion services, see guidance on mobile IV therapy billing and the best IV therapy EMR options.

Pabau’s claims management software brings pre-submission validation, documentation capture, and claim tracking into a single workflow, rather than requiring separate tools for each step.

Conclusion

B4172 denials are rarely random. They follow predictable patterns: wrong concentration code, missing KX modifier, insufficient documentation, or incorrect billing units. Each of these is preventable with the right pre-submission checks in place.

Pabau’s claims management software validates these claims before submission, helping infusion providers and DME suppliers catch issues early and reduce denial rates without adding manual review steps. To see how it works for your billing team, book a demo.

Continue your research

Running an IV therapy or infusion service? IV therapy EMR software covers the features infusion practices need for compliant documentation and efficient scheduling.

Frequently asked questions